Cargando…

Resistance of human T-CFUcs to activated cyclophosphamide: a feature common with critical marrow stem cells?

Detalles Bibliográficos
Autores principales:	Byfield, J. E., Calabro-Jones, P. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1985
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977205/ https://www.ncbi.nlm.nih.gov/pubmed/3876106

Ejemplares similares

The proliferation of multiple myeloma colonies (MY-CFUc) in vitro is independent of prognosis and is not associated with mutated N- or K-ras alleles in human bone marrow aspirates.
por: Millar, B. C., et al.
Publicado: (1995)

Therapeutic potential of bone marrow mesenchymal stem cells in cyclophosphamide-induced infertility
por: Ibrahim, Dalia, et al.
Publicado: (2023)

Nitrergic Response TO Cyclophosphamide Treatment in Blood and Bone Marrow
por: Kevorkian, G.A, et al.
Publicado: (2008)

Mice, men, mustard and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents.
por: Byfield, J. E., et al.
Publicado: (1981)

Bone marrow mesenchymal stem cell repair of cyclophosphamide-induced ovarian insufficiency in a mouse model
por: Badawy, Ahmed, et al.
Publicado: (2017)

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
por: Munchel, Ashley, et al.
Publicado: (2011)

Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes
por: Klein, Orly R., et al.
Publicado: (2020)

Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide
por: Al Malki, Monzr M., et al.
Publicado: (2022)

Thermochemotherapy-induced resistance to cyclophosphamide.
por: Urano, M., et al.
Publicado: (1988)

Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow.
por: Ono, K., et al.
Publicado: (1986)

Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamide.
por: Millar, J. L., et al.
Publicado: (1978)

Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update
por: Patel, Dilan A., et al.
Publicado: (2020)

A Review of Cyclophosphamide-Induced Transplantation Tolerance in Mice and Its Relationship With the HLA-Haploidentical Bone Marrow Transplantation/Post-Transplantation Cyclophosphamide Platform
por: Mayumi, Hisanori
Publicado: (2021)

Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation.
por: Lee, S. M., et al.
Publicado: (1992)

Carnosine attenuates cyclophosphamide-induced bone marrow suppression by reducing oxidative DNA damage
por: Deng, Jie, et al.
Publicado: (2017)

Evidence for the active intermediate in cyclophosphamide metabolism.
por: Cox, P. J.
Publicado: (1973)

Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
por: Podgurskaya, A. D., et al.
Publicado: (2021)

Myeloprotective activity of crude methanolic leaf extract of Cassia occidentalis in cyclophosphamide-induced bone marrow suppression in Wistar rats
por: Neboh, Emeka E, et al.
Publicado: (2015)

Where is the common ground between bone marrow mesenchymal stem/stromal cells from different donors and species?
por: Jones, Elena, et al.
Publicado: (2015)

Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib
por: Alexandru, Daniela, et al.
Publicado: (2009)

Bone marrow stem cell injection for the treatment of critical limb ischemia
por: Shindo, S
Publicado: (2007)

Cimetidine enhancement of cyclophosphamide antitumour activity.
por: Dorr, R. T., et al.
Publicado: (1982)

Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy
por: Arai, Yasuyuki, et al.
Publicado: (2015)

The Critical Role of Long Noncoding RNA in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells
por: Qiu, Xiaoling, et al.
Publicado: (2017)

Protective Effect of Royal Jelly against Cyclophosphamide-Induced Thrombocytopenia and Spleen and Bone Marrow Damages in Rats
por: Khazaei, Fatemeh, et al.
Publicado: (2020)

Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
por: Mehta, Rohtesh S., et al.
Publicado: (2021)

Progressive substitution of posttransplant cyclophosphamide with bendamustine: A phase I study in haploidentical bone marrow transplantation
por: Katsanis, Emmanuel, et al.
Publicado: (2020)

Characterization of Human, Ovine and Porcine Mesenchymal Stem Cells from Bone Marrow: Critical In Vitro Comparison with Regard to Humans
por: Westerkowsky, Elisa Katja, et al.
Publicado: (2023)

Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide
por: Kanakry, Christopher G., et al.
Publicado: (2017)

CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow
por: Nakamura-Ishizu, Ayako, et al.
Publicado: (2015)

T‐cell modulation by cyclophosphamide for tumour therapy
por: Hughes, Ellyn, et al.
Publicado: (2018)

The impact of Host vs. Graft mismatches on rejection of haploidentical bone marrow transplants in thalassemia patients using posttransplant cyclophosphamide
por: Marwah, Priya, et al.
Publicado: (2019)

Loss of the Mismatched Human Leukocyte Antigen Haplotype in Two Acute Myelogenous Leukemia Relapses after Haploidentical Bone Marrow Transplantation with Posttransplantation Cyclophosphamide
por: McCurdy, Shannon R., et al.
Publicado: (2016)

Polysaccharides from the root of Angelica sinensis protect bone marrow and gastrointestinal tissues against the cytotoxicity of cyclophosphamide in mice
por: Hui, Marco K. C., et al.
Publicado: (2006)

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
por: Williams, Louis, et al.
Publicado: (2020)

Protopanaxadiol manipulates gut microbiota to promote bone marrow hematopoiesis and enhance immunity in cyclophosphamide‐induced immunosuppression mice
por: Cao, Yuru, et al.
Publicado: (2023)

Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
por: Pujade-Lauraine, Eric
Publicado: (2013)

Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow—Review of Published Literature
por: Farhan, Shatha, et al.
Publicado: (2016)

Protective effect of bone marrow mesenchymal stem cell-derived exosomes against the reproductive toxicity of cyclophosphamide is associated with the p38MAPK/ERK and AKT signaling pathways
por: Guo, Xiao-Bin, et al.
Publicado: (2021)

Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide
por: Navarro, Sandi L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kgmu3fpm08s4dttqt5cvcpqqp8